Teva Pharmaceutical Industries Ltd. (TEVA): שולי רווח תפעולי ממכירות

לוגו של חברה ציבורית Teva (TEVA)

The global ecosystem of Teva Pharmaceutical Industries (TEVA) integrates the production of original biologics and generics, creating a reliable sales channel. Operating margin fluctuations confirm the resilience of this model, with the indicator holding at 19.20. Efficiency is supported by decentralized manufacturing, which reduces transportation costs. Stability is further ensured by the absence of key scientist attrition and the targeted hiring of biosimilar specialists.

TEVA: שולי רווח תפעולי Teva Pharmaceuticals 04.07.2022 - 20.11.2026

Teva Pharmaceutical Industries Ltd. (TEVA) - פילוחי מדדים ודוחות פיננסיים

- מחיר מניה וקונצנזוס הערכת שווי:
הערכת שווי פונדמנטלית של החברה:Teva, TEVA
מוצר עיקרי של Teva Pharma

Operating margin measures the share of profit from core operations before financial expenses and taxes, demonstrating the efficiency of internal cost management. Analyzing the operating profit margin reveals how biosimilar sales growth and reduced generic costs at Teva Pharmaceutical Industries (TEVA) are boosting core profitability, establishing the foundation for realizing the long-term potential of the company's innovative portfolio.